Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Clinical trial NCT06334432 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06334432
Sponsor: Nuvation Bio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor HER2-negative Breast Cancer Metastatic Castration-resistant Prostate Cancer (mCRPC)Pancreatic Cancer Platinum-resistant Ovarian Cancer (PROC)

Start date: 2024-03-14
Primary completion: 2027-03-01
Enrollment: 466

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.